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httpAge does not predict need for reintervention in
patients with critical limb ischemia
Daniel J. Torrent, MD, MPH,a Jill N. Zink, MD,a William M. Bogey, MD,a C. Steven Powell, MD,a
Frank M. Parker, MD,a Dean J. Yamaguchi, MD,a and Michael Clinton Stoner, MD, RVT,b Greenville, NC;
and Rochester, NY
Objective: Conventional wisdom holds that patients with a need for intervention for femoropopliteal occlusive disease at a
younger age have more aggressive disease, although there is a paucity of support in the literature. The purpose of this
study was to evaluate this assumption.
Methods: A retrospective cohort of patients undergoing endovascular or open revascularization for femoropopliteal
occlusive disease for critical limb ischemia during a 4-year period was assembled. Demographic information, comor-
bidities, disease characteristics, and time to last follow-up, repeat intervention, amputation, or death was recorded. The
patients were stratiﬁed by age into a young (#55 years) group, middle (56-77 years) group, and elderly ($78 years)
group. Univariate and multivariate statistical methods were used to evaluate the primary outcome.
Results: The study included 124 patients with a mean age of 64.4 6 0.8 years. Progression to reintervention or ampu-
tation occurred in 50% of the patients during the follow-up period, with 18% dying before having an outcome. Kaplan-
Meier analysis showed a trend toward signiﬁcance (P [ .06) in time to reintervention, amputation, or death among the
three groups, with time to event of 253, 1083, and 504 days for the young, middle, and elderly groups, respectively.
However, differences based on age were not signiﬁcant (P [ .57) in Cox regression analysis.
Conclusions: There does not appear to be an association between time to reintervention and patient age. (J Vasc Surg
2015;61:413-8.)Peripheral arterial disease (PAD) is often associated
with increasing age. Estimates are that 10% of people
aged >65 years and 20% aged >75 years in the Western
world have this disease process.1 PAD can also be seen in
younger patients, however, with up to 28% of PAD patients
aged <65 years.2 Onset at an age of <50 years is deﬁned
as premature.3 Some believe that those with younger age
at onset have a more aggressive atherosclerotic disease
process.4
Despite conventional wisdom that patients presenting
with PAD at a younger age have a more aggressive disease
process, there is scant supporting evidence in the literature.
The objective of this study was to investigate the relation-
ship between age and progression to reintervention or
amputation after intervention for femoropopliteal occlusive
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In this retrospective study, a cohort of all patients
undergoing an open or endovascular intervention for critical
limb ischemia secondary to femoropopliteal occlusive disease
from July 2003 through July 2006 was identiﬁed by Com-
mon Procedural Terminology codes (AmericanMedical As-
sociation, Chicago, Ill), and a database was constructed with
Institutional Review Board approval. As a retrospective
study, informed consent was not obtained because patients
were not placed at risk and many were lost to follow-up or
had died. The decision for an open or endovascular interven-
tion had been determined according to clinical evaluation,
anatomic factors, and surgeon preference. The medical re-
cord for each patient was reviewed to record demographics,
preoperative factors, procedural factors, and outcomes.
Comorbid conditions and smoking status were also
recorded. The comorbidities were deﬁned as diabetes (by
medical treatment), hypertension (by medical treatment),
hyperlipidemia (by medical treatment or total cholesterol
>200 mg/dL), tobacco use (lifetime and current use), cor-
onary disease (by medical treatment or history of coronary
intervention), renal insufﬁciency (by creatinine >1.5 mg/
dL), and end-stage renal disease (ESRD; by renal failure
with chronic renal replacement therapy).
The record was reviewed for the end points of death,
endovascular or open reintervention on the index extrem-
ity, amputation, or the end of the follow-up period in
August 2013.
The population was divided into the oldest quartile,
youngest quartile, and a ﬁnal group consisting of the413
Table I. Overall population demographics, disease at
presentation, comorbidities, and outcomes
Variable
Mean 6 SE,a No. (%),
or median (95% CI)
Age, years 66.5 6 1.2
Age groups, years
#55 32 (26)
56-76 60 (48)
$78 32 (26)
Female 62 (50)
Diabetes mellitus
Insulin-dependent 14 (11)
Noninsulin-dependent 49 (40)
Hypertension 94 (76)
Hyperlipidemia 55 (44)
Smoker 66 (53)
Former smoker 24 (19)
ESRD 19 (15)
CAD 50 (40)
Congestive heart failure 37 (30)
Open procedure 90 (73)
Reintervention or amputation 68 (55)
Death before outcome 23 (19)
Time to outcome or death, months 10 (6.3-20.9)
CAD, Coronary artery disease; CI, conﬁdence interval; ESRD, end-stage
renal disease; SE, standard error.
aExcept as noted for time to outcome or death.
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used to deﬁne general population characteristics and char-
acteristics of the individual age groups.
Because of the small size of the sample, a power anal-
ysis was undertaken. Kaplan-Meier survival analyses were
performed for the overall group and for the individual
age groups. The end point for these analyses was time to
reintervention or amputation. Patients who were lost to
follow-up or did not reach either end point at the time
of termination of follow-up were censored. Because of a
higher rate of death expected in the elderly group, this
analysis was inherently biased because of the strong possi-
bility of shorter follow-up times in this group. For this
reason, a separate analysis was done with reintervention,
amputation, or death as the end point.
Cox regression analysis was performed for Kaplan-Meier
survival curves with P # .20, with time to reintervention or
amputation as the end point to further investigate the link
between age group and primary outcomes when controlling
for possible confounders. A separate analysis was done using
reintervention, amputation, or death as the end point
because of the possible confounding effect of a higher death
rate in the elderly patients. All potential confounders from
our data were included in the original model, and stepwise
backwards selection was used to arrive at the ﬁnal model.RESULTS
The study population included 124 patients with a
mean age of 66.5 6 1.2 years. The mean follow-up time
was 22.6 6 2.7 months. Noninsulin-dependent diabetes
mellitus was present in 40%, and insulin-dependent dia-
betes mellitus was present in 11%. Progression to repeat
intervention occurred in 55% of patients, and 19% died
before having an outcome. Table I summarizes the overall
population characteristics.
Table II reports the demographics, comorbidities, and
outcomes for the different groups. There were signiﬁcant
differences in gender (P ¼ .03), smoking (P ¼ .0005),
congestive heart failure (P ¼ .02), and death before an
event happened (P ¼ .03).
Based on a sample size of 124 patients, a standard error
of 32, and an a of .05, the power of this study was 0.720.
The young group (age #55 years; n ¼ 32) was a mean
age of 48.9 6 1.0 years. Of these, 38% were women, 9.4%
had quit smoking, 8% had an open procedure. Progression
to reintervention or amputation occurred in 69%, and 6%
died before an outcome occurred.
The middle group (age 56-77 years; n ¼ 60) was a
mean age of 66.6 6 0.7 years. Former smokers made up
23% of this group, and 75% had an open procedure. Pro-
gression to reintervention or amputation occurred in
55%, and 18% died before reaching an outcome.
The elderly group (age $78 years; n ¼ 32) was a mean
age of 83.7 6 1.0 years. Women made up 68.8% of this
group, 22% were former smokers, and 63% had an open pro-
cedure. Progression to reintervention or amputation
occurred in 41%, and 31% died before reaching an outcome.Kaplan-Meier survival analysis for time to reinterven-
tion or amputation (Fig 1) showed no signiﬁcant differ-
ence among groups (P ¼ .23), with median times to
reintervention or amputation of 8.3 months for the young
group and 15.9 months for middle group. The elderly
group did not have a median time because <50% had an
outcome due mostly to 31% having died during follow-
up before having an event.
The Kaplan-Meier survival analysis for reintervention,
amputation, or death (Fig 2) showed no signiﬁcant differ-
ence among the age groups (P ¼ .97). Median time to rein-
tervention, amputation, or death was 301 days. Median
times to intervention or death for the young, middle, and
elderly groups were 5.1, 11.6, and 10.0 months, respectively.
To ensure that the group meeting the criteria for pre-
mature PAD within the young group was not signiﬁcantly
different from the group that did not, the number of events
and the time to events were examined for these two
groups. There were 16 (50%) patients in this group
meeting criteria for premature PAD. For both groups,
31% progressed to reintervention or amputation (P ¼
1.00). Death before an event occurred in 6% of both
groups (P ¼ 1.00). On Kaplan-Meier analyses, there
were no signiﬁcant differences in time to reintervention
or amputation (P ¼ .46), or reintervention, amputation,
or death (P ¼ .45) between the premature PAD patients
and the rest of the young group.
On Cox regression for reintervention or amputation,
age group was not a signiﬁcant factor (P ¼ .25) when con-
trolling for potential confounders (Table III). Quitting
smoking was protective against progression (relative risk
Fig 1. Kaplan-Meier survival curves for time to reintervention or amputation for young (solid line), middle
(dotted line), and elderly (dashed line) patients (P ¼ .23).
Table II. Demographics, disease at presentation, comorbidities, and outcomes by age group
Variablea Young (n ¼ 32) Middle (n ¼ 60) Elderly (n ¼ 32) P
Age, years 48.9 6 1.0 66.6 6 0.7 83.3 6 1.0 <.0001
Female 12 (38) 28 (47) 22 (68.8) .03
Diabetes mellitus
Insulin dependent 3 (9) 7 (12) 4 (13) .92
Noninsulin dependent 15 (47) 26 (43) 8 (25) .13
Hypertension 23 (72) 47 (78) 24 (75) .78
Hyperlipidemia 17 (53) 28 (47) 10 (31) .18
Smoker 18 (52) 40 (67) 8 (25) .005
Former smoker 3 (9) 14 (23) 7 (22) .21
ESRD 7 (22) 11 (19) 1 (3) .0.04
CAD 17 (53) 21 (35) 12 (38) .23
Congestive heart failure 5 (16) 17 (28) 15 (47) .02
Open procedure 25 (78) 45 (75) 20 (63) .33
Reintervention or amputation 22 (69) 33 (55) 13 (41) .08
Death before event 2 (6) 11 (18) 10 (31) .03
Time to death or event, months 5.1 (3.8-26.0) 11.6 (7.7-32.7) 10.0 (2.8-40.8) .97
CAD, Coronary artery disease; CI, conﬁdence interval; ESRD, end-stage renal disease; SE, standard error.
aContinuous variables are shown as mean 6 SE or median (95% CI) and categorical variables as number (%).
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Having an open procedure strongly trended toward sig-
niﬁcance (RR, 0.60; 95% CI, 0.35-1.03). ESRD was
associated with progression to the primary end points
(RR, 2.56; 95% CI, 1.29-4.86). Coronary artery disease
(CAD) was also associated with a decreased likelihood of
progression of disease (RR, 0.44; 95% CI, 0.25-0.76).
Those with CAD were more likely to have died before
reaching an event (P ¼ .07): 30% of patients with CAD
compared with 10% without CAD died before having an
outcome.
On Cox regression for reintervention, amputation, or
death, age group was not a signiﬁcant factor (P ¼ .97)
when controlling for potential confounders (Table IV).An open procedure was associated with a decreased risk
of progression (RR, 0.58; 95% CI, 0.36-0.93). Having
quit smoking was also protective (RR, 0.53; 95% CI,
0.29-0.91). ESRD was associated with increased risk of
progression (RR, 2.48; 95% CI, 1.38-4.26). Gender and
quitting smoking were not signiﬁcant but neared signiﬁ-
cance and remained in the model.
DISCUSSION
Early onset of PAD symptoms is often assumed to be
attributable to an accelerated atherosclerotic process.5
That patients presenting at younger ages go on to require
more interventions has also been noted.4 Going along with
this, a study of patients aged <45 years found that 41%
Table III. Cox regression for risk of progression to
reintervention or amputation (P ¼ .0005)
Variable RR 95% CI P
Age group, years .25
#55 vs 56-77 1.63 0.90-2.90
#55 vs $78 1.57 0.77-3.34
CAD 0.44 0.25-0.76 .003
Former smoker 0.46 0.21-0.91 .02
ESRD 2.56 1.29-4.86 .008
Open procedure 0.60 0.35-1.03 .06
CI, Conﬁdence interval; CAD, coronary artery disease; ESRD, end-stage
renal disease; RR, relative risk.
Table IV. Cox regression for risk of progression to
reintervention, amputation, or death (P ¼ .0007)
Variable RR 95% CI P
Age group, years .97
#55 vs 56-77 0.97 0.57-1.61
#55 vs $78 0.93 0.49-1.75
Smoker 0.67 0.42-1.09 .11
Former smoker 0.53 0.29-0.91 .02
ESRD 2.48 1.38-4.26 .003
Open procedure 0.58 0.36-0.93 .03
CI, Conﬁdence interval; ESRD, end-stage renal disease; RR, relative risk.
Fig 2. Kaplan-Meier survival curves for time to reintervention, amputation, or death for young (solid line), middle
(dotted line), and elderly (dashed line) patients (P ¼ .97).
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for progression of their disease or graft failure.3
There is evidence that patients presenting with prema-
ture PAD can go on to poor outcomes. Repeated athe-
roembolic events and lack of collaterals have been noted
to sometimes lead to rapid deterioration toward critical
limb ischemia in the population.6 Early bypass failure and
amputation have also been reported.3 Other studies have
looked into potential causes, with a series of 51 patients
with premature PAD ﬁnding that 90% had laboratory
abnormalities.7
As with these studies, we also found poor outcomes in
the young population. With a mean age of 48.96 1.0 years,
our young group was largely in the range of premature
PAD. Half of this group met criteria for premature PAD.
Within the young group, comparing those who did and
did not meet criteria for premature PAD (age $50) found
no differences in reintervention or amputation, death
before reintervention, or death. There was also no differ-
ence in time to event on either analysis. In the 10 years
of follow-up from initiation of the record review, 6% haddied and 66% progressed to reintervention or amputation
after the initial intervention. However, unlike the prior
listed studies, we were able to compare this group with
older groups. The incidence of death during the time frame
of this study was signiﬁcantly higher in the elderly group
(31%).
We used the time frame of 2003 to 2006 to draw our
patient sample from to allow w10 years of follow-up. The
mean follow-up time was w2.5 years, which was largely
related to many of the events occurring within that time
frame. In addition, with the advancement of endovascular
techniques in later years, this would have added to the po-
tential for a more heterogeneous sample and confounding.
Death is a potential confounder. Death removes a
larger subset of the older individuals from the at-risk
pool. When death was controlled for in the Kaplan-Meier
survival analysis, there was no signiﬁcant difference among
the groups.
Open procedures have been associated with longer
patency.8 Our data support this, with a signiﬁcant result
on the Cox regression analysis that included death and a
strong trend toward signiﬁcance on the other. The
JOURNAL OF VASCULAR SURGERY
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ysis has the potential to confound our results, because the
failure modes for endovascular and open procedures are
different. However, univariate analysis found no association
among the age groups and the procedure type (P ¼ .33).
This issue was further controlled for on multivariate anal-
ysis. Because of the number of individuals involved,
breaking down the analysis into endovascular and open
groups would result in too small a sample to analyze. On
the basis of the design of our study, comparing if failure
across groups was related to atherosclerotic progression
or intimal hyperplasia was not possible.
A study by Harris et al9 found similar results in elevated
poor overall outcome rates in the younger population.
They had 76 patients with premature PAD and 76 patients
aged >60 years matched for disease distribution and found
an increased prevalence of late amputations in the study
group compared with the control group (26% vs 1.73%;
P < .0001). However, it should be noted that the
follow-up times were 62 6 48 months for the study group
and 33.4 6 27 months for the control group.9
Our univariate analysis showed a higher proportion of
patients in the young group progressed to reintervention
or amputation compared with the other two groups. This
was not statistically signiﬁcant (P ¼ .08), although it
does strongly trend in that direction. This was offset by
the fact that higher proportions of individuals in the two
older groups died before having an outcome (P ¼ .03).
When reintervention, amputation, and death are taken
into account in the Kaplan-Meier analysis, there is no dif-
ference among groups (P ¼ .97).
As in the Harris et al10 study, we found an increased
prevalence of female patients in the older group. PAD is
not as prevalent in premenopausal women, but after meno-
pause, the prevalence increases and is similar to the preva-
lence in men.10 This is similar to what occurs in our data
and is concerning because prior research has shown that fe-
male gender is an independent risk factor for amputation.11
However, other studies have shown no signiﬁcant difference
between men and women in outcomes.12 In our data,
gender had no effect on the primary outcomes, and this var-
iable was not signiﬁcant in the Cox regression model.
If premature PAD in our population does not progress
more rapidly after the initial procedure, then the question is
raised why these patients are developing disease at a young
age. This may be related to other risk factors. Our young
and middle groups were more likely to be smokers than
the elderly group; in addition, the young group was the
least likely to have quit smoking. Our young group was
the most likely to have ESRD. Smoking and ESRD are
well-known risk factors for disease progression.13,14
It is interesting that CAD appeared to be a protective
factor for disease progression in the Cox model only taking
into account reintervention and amputation as the end
point. CAD disappears a signiﬁcant factor when death is
taken into account. On closer analysis, CAD appears to
be a marker of patients more likely to die before reaching
reintervention or amputation. Almost one in three of thepatients with CAD compared with only one in 10 without
CAD died before reaching an outcome.
The possibility exists that there are subsets of patients
with premature PAD who will progress; however, that
was beyond the scope of this study. In addition, that pos-
sibility holds true across age groups.
Our sample was limited to patients with femoropopli-
teal disease, which is a potential limitation to this study.
This facilitated comparison of a more homogenous popula-
tion with similar lesions. However, this excludes the possi-
bility of studying multilevel disease and whether prevalence
is associated with age and its relationship with our end
points.
CONCLUSIONS
Patients presenting with symptomatic PAD at a
younger age are commonly assumed to represent a popula-
tion with more aggressive disease; however, age was not an
independent risk factor for disease progression after the
ﬁrst intervention. The higher prevalence of repeat interven-
tions and progression to amputation in younger patients
are more likely related to a longer lifespan compared with
the older group. In addition, the young age at presentation
may relate to other risk factors.
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